S&P 500 Industrials Sector SEC Filings — February 19, 2026

20-02-2026

Skyline Bankshares, Inc. filed an 8-K on February 20, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a voluntary informational filing with no quantified impacts reported.

20-02-2026

Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. Specific details of the other events or the nature of the financial statements and exhibits are NOT_DISCLOSED. No quantitative financial metrics, transactions, or performance comparisons are provided in the filing summary.

20-02-2026

Nicolet Bankshares Inc filed an 8-K on February 20, 2026, reporting the completion of an acquisition or disposition of assets under Item 2.01. The filing also covers departures or elections of directors/officers and compensatory arrangements under Item 5.02, Regulation FD disclosure under Item 7.01, and financial statements/exhibits under Item 9.01. No quantitative metrics, transaction values, parties involved, or performance comparisons are disclosed.

20-02-2026

Balchem Corp filed an 8-K on February 20, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. This is a multi-item filing related to financial results. No specific revenue, earnings, margins, comparisons, guidance, or other quantitative metrics were provided in the filing details.

20-02-2026

COGENT COMMUNICATIONS HOLDINGS, INC. filed an 8-K on February 20, 2026 (AccNo: 0001104659-26-017862), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a standard disclosure for financial results, but no specific revenue, earnings, margins, guidance, or other quantitative metrics—positive, negative, or flat—are disclosed in the provided filing information. Sector details are not specified.

20-02-2026

TELEPHONE & DATA SYSTEMS INC /DE/ filed an 8-K on February 20, 2026 (AccNo: 0001051512-26-000009), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is a multi-item informational filing typical for earnings announcements.

20-02-2026

Sonoco Products Co filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 referencing attached financial statements and exhibits. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons for change, or timing are provided. Critical information such as names, titles, and context is NOT_DISCLOSED, limiting assessment of governance or market impact.

20-02-2026

Dine Brands Global, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited transparency on content.

20-02-2026

MainStreet Bancshares, Inc. filed a Form 8-K on February 20, 2026, reporting solely under Item 8.01 Other Events. No specific details regarding the nature of the other event, financial metrics, transaction values, or impacts are disclosed in the provided filing information. This appears to be a single-item, potentially voluntary disclosure with no quantitative data available.

20-02-2026

Vistagen Therapeutics, Inc. filed an 8-K on 2026-02-20 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the available information. No positive or negative metrics, board composition changes, or governance implications are explicitly stated.

20-02-2026

FIRST MID BANCSHARES, INC. filed an 8-K on 2026-02-20 reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No specific details on the agreement, transaction value, terms, or financial impact are provided.

20-02-2026

SAN JUAN BASIN ROYALTY TRUST filed an 8-K on February 20, 2026, under Item 8.01 reporting Other Events. No specific event details, financial metrics, positive or negative changes, or quantitative data are disclosed in the provided filing information.

20-02-2026

Western Alliance Bancorporation filed an 8-K on February 20, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the nature of the other events or contents of the exhibits are provided in the filing summary.

20-02-2026

ERIE INDEMNITY CO filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements and exhibits under Item 9.01. Specific details including the key position affected, names of individuals, appointment or resignation status, reasons for change, and any quantitative data such as compensation amounts are NOT_DISCLOSED. No positive or negative metrics, period-over-period comparisons, or financial impacts are mentioned.

20-02-2026

CHOICE HOTELS INTERNATIONAL INC /DE filed an 8-K on 2026-02-20 (AccNo: 0001628280-26-010118, Size: 145 KB) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individual names, appointment or resignation status, reasons for change, or timing are explicitly stated. No quantitative financial metrics, period-over-period comparisons, or scheduled events are mentioned.

20-02-2026

UNITED BANCORP INC /OH/ filed a Form 8-K on February 20, 2026, disclosing Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details regarding the nature of the other events, transaction values, financial metrics, or exhibits are provided in the filing summary. This is a multi-item informational filing with no quantified positive or negative impacts mentioned.

20-02-2026

Sunshine Biopharma Inc. filed an 8-K on February 20, 2026, reporting under Item 5.07: Submission of Matters to a Vote of Security Holders. No details on specific proposals, vote outcomes, or results are disclosed. This appears to be a routine disclosure of shareholder meeting matters with no financial or operational metrics provided.

20-02-2026

Grayscale CoinDesk Crypto 5 ETF filed a Form 8-K on February 20, 2026, reporting under Item 8.01 Other Events. No specific details on the nature of the events, financial metrics, transactions, or quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure with no mentioned positive or negative impacts.

20-02-2026

Scotts Miracle-Gro Co filed an 8-K on February 20, 2026, under Item 2.02 announcing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific revenue, earnings, guidance, comparisons, or other metrics are disclosed in the provided filing information.

20-02-2026

Serve Robotics Inc. /DE/ filed an 8-K on 2026-02-20 announcing the completion of an acquisition or disposition of assets under Item 2.01, with financial statements and exhibits provided under Item 9.01. No specific details on transaction parties, structure, valuation, or strategic rationale are disclosed. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.

• ·Filing Accession Number: 0001213900-26-018806
• ·File Size: 1 MB
• ·Sector: NOT_DISCLOSED

20-02-2026

Mercer Bancorp, Inc. filed a Form 8-K on February 20, 2026, under Item 5.07 disclosing the submission of matters to a vote of security holders. No specific proposals, vote outcomes, share counts, or other details are provided in the filing summary. This is an informational disclosure with no financial metrics, positive or negative changes, or quantitative data mentioned.

20-02-2026

Hecla Mining Co/DE/ filed an 8-K on 2026-02-20 (AccNo: 0001437749-26-004900) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as key position affected, names, appointment or resignation status, reasons, timing, or quantitative data are disclosed in the provided information. No positive or negative metrics, scheduled events, or governance impacts are mentioned.

20-02-2026

Fennec Pharmaceuticals Inc. filed a Form 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, or any quantitative metrics are disclosed in the provided filing information.

20-02-2026

Arbutus Biopharma Corp filed a Form 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed in the provided filing information. No financial metrics, transactions, or performance data are mentioned.

20-02-2026

Abbott Laboratories filed an 8-K on February 20, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative metrics, financial impacts, or specific details on the amendments are provided.

20-02-2026

Entergy Corp /DE/ filed an 8-K on February 20, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of the financial statements and exhibits are disclosed in the filing summary provided. This is a multi-item filing with no quantitative metrics, positive or negative changes, or performance comparisons mentioned.

20-02-2026

Texas Capital Bancshares Inc/TX filed an 8-K on February 20, 2026, under Item 5.03 disclosing amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 references financial statements and exhibits. No specific details, quantitative metrics, positive or negative impacts, or further context on the changes are provided in the filing summary.

20-02-2026

Faraday Future Intelligent Electric Inc. filed a Form 8-K on 2026-02-20 under Item 3.03 disclosing material modifications to rights of security holders and under Item 5.03 reporting amendments to articles of incorporation or bylaws or a change in fiscal year. Item 9.01 provides for financial statements and exhibits. No specific details, numerical values, positive or negative impacts, or further context on the changes are disclosed in the provided filing summary.

• ·AccNo: 0001213900-26-018808
• ·File Size: 295 KB

20-02-2026

SOUTHSIDE BANCSHARES INC filed an 8-K on February 20, 2026 (AccNo: 0000705432-26-000029), disclosing developments under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were provided. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are disclosed.

20-02-2026

Oramed Pharmaceuticals Inc. filed an 8-K on February 20, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details, transaction values, financial metrics, positive or negative impacts, or period-over-period comparisons are provided in the filing summary. This is a multi-item filing with no disclosed quantitative data or strategic context.

20-02-2026

Marriott International Inc. filed an 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the content of the financial statements and exhibits are disclosed in the provided filing information. This appears to be a voluntary informational disclosure with no quantitative financial metrics or directional impacts mentioned.

20-02-2026

ICU Medical Inc/DE filed an 8-K on 2026-02-20 disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the key position affected, names of individuals, appointment or resignation status, reasons for the change, or any financial metrics are disclosed in the provided filing information. This appears to be a routine disclosure of a leadership-related event without additional quantitative or qualitative context.

20-02-2026

NovaBay Pharmaceuticals, Inc. filed an 8-K on February 20, 2026, disclosing under Item 3.03 material modifications to the rights of security holders and under Item 5.03 amendments to its articles of incorporation or bylaws or a change in fiscal year. Item 9.01 lists financial statements and exhibits. No specific details, financial impacts, or quantitative metrics regarding these changes are provided.

20-02-2026

M2i Global, Inc. filed a Form 8-K on February 20, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses financial statements and exhibits. No specific details on the nature of the amendments, changes, financial impacts, or quantitative metrics are provided in the filing summary.

20-02-2026

ARtelligence Holdings, Inc. filed a Form 8-K on February 20, 2026 (AccNo: 0001477932-26-000953, Size: 130 KB), reporting solely under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, quantitative data, or specific disclosure content are provided in the filing information. This appears to be a single-item voluntary filing for fair disclosure compliance.

20-02-2026

First Guaranty Bancshares, Inc. filed an 8-K on February 20, 2026 (AccNo: 0001408534-26-000007), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period changes, guidance, or other quantitative financial details are provided in the available filing information. This appears to be a standard voluntary earnings-related disclosure without detailed performance indicators.

20-02-2026

Orange County Bancorp, Inc. /DE/ filed an 8-K on February 20, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. This is a multi-item filing with no quantitative metrics, transaction details, or performance comparisons mentioned.

• ·Accession Number: 0001104659-26-018183
• ·File Size: 220 KB

20-02-2026

Phoenix Motor Inc. filed an 8-K on February 20, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for the change, or timing are disclosed. Sector is not specified.

20-02-2026

U S GLOBAL INVESTORS INC filed an 8-K on February 20, 2026, under Item 2.02 announcing results of operations and financial condition. Item 9.01 includes financial statements and exhibits. No specific financial metrics, period-over-period changes, or guidance are disclosed in the provided filing details.

20-02-2026

Advantage Solutions Inc. filed an 8-K on 2026-02-20 disclosing an officer or director change under Item 5.02, covering departures, elections, appointments of certain officers, and compensatory arrangements. Item 9.01 indicates financial statements and exhibits are included. No specific names, positions affected, reasons for change, financial metrics, or other quantitative details are disclosed.

20-02-2026

Regional Management Corp. filed an 8-K on February 20, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details regarding the content of the Regulation FD disclosure, financial metrics, transactions, or events are provided in the filing summary. No quantitative data, period-over-period comparisons, or scheduled events are disclosed.

20-02-2026

Idea Acquisition Corp. filed an 8-K on 2026-02-20 under Items 8.01 (Other Events) and 9.01 (Financial Statements and Exhibits), labeled as a Merger/Acquisition event. No specific details on deal structure, parties involved, valuation, financial metrics, or strategic rationale were explicitly stated in the provided filing summary. All quantitative data and transaction specifics are NOT_DISCLOSED.

• ·AccNo: 0001104659-26-018207
• ·File size: 415 KB
• ·Sector: not specified

20-02-2026

SmartStop Self Storage REIT, Inc. filed an 8-K on 2026-02-20 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics were disclosed.

20-02-2026

Bayview Acquisition Corp filed an 8-K on 2026-02-20 (AccNo: 0001493152-26-007621, Size: 266 KB) under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No transaction details, financial metrics, parties involved, or quantitative deal terms were disclosed. No positive or negative performance metrics were mentioned.

20-02-2026

Community West Bancshares filed an 8-K on 2026-02-20 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or quantitative impacts are disclosed.